Systematic elucidation of genetic mechanisms underlying cholesterol uptake

Marisa C. Hamilton(Brigham and Women's Hospital), James D. Fife(Brigham and Women's Hospital), Ersin Akıncı(Brigham and Women's Hospital), Tian Yu(Brigham and Women's Hospital), Benyapa Khowpinitchai(Brigham and Women's Hospital), Minsun Cha(Brigham and Women's Hospital), Sammy Barkal(Brigham and Women's Hospital), Thi Tun Thi(National University of Singapore), Grace H.T. Yeo(Massachusetts Institute of Technology), Juan Pablo Ramos Barroso(Brigham and Women's Hospital), Matthew Francoeur(Brigham and Women's Hospital), Minja Velimirovic(Brigham and Women's Hospital), David K. Gifford(Massachusetts Institute of Technology), Guillaume Lettre(Montreal Heart Institute), Haojie Yu(National University of Singapore), Christopher A. Cassa(Brigham and Women's Hospital), Richard I. Sherwood(Brigham and Women's Hospital)
Cell Genomics
April 21, 2023
Cited by 16Open Access
Full Text

Abstract

Genetic variation contributes greatly to LDL cholesterol (LDL-C) levels and coronary artery disease risk. By combining analysis of rare coding variants from the UK Biobank and genome-scale CRISPR-Cas9 knockout and activation screening, we substantially improve the identification of genes whose disruption alters serum LDL-C levels. We identify 21 genes in which rare coding variants significantly alter LDL-C levels at least partially through altered LDL-C uptake. We use co-essentiality-based gene module analysis to show that dysfunction of the RAB10 vesicle transport pathway leads to hypercholesterolemia in humans and mice by impairing surface LDL receptor levels. Further, we demonstrate that loss of function of OTX2 leads to robust reduction in serum LDL-C levels in mice and humans by increasing cellular LDL-C uptake. Altogether, we present an integrated approach that improves our understanding of the genetic regulators of LDL-C levels and provides a roadmap for further efforts to dissect complex human disease genetics.


Related Papers